A Research Study to Show Aprocitentan is Efficacious and Safe to Treat Patients With Uncontrolled Blood Pressure and Chronic Kidney Disease.
Clinical trial NCT04162366 · WITHDRAWN
Trial details
- NCT number
- NCT04162366
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-01
- Primary completion
- 2021-06-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.